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ABSTRACT: A copper-catalyzed carboarylation-ring closure strategy was used for the modular synthesis of oxazolines the reac-
tion of 1-aryl-propargylamides and diaryliodonium salts. The novel approach enables the efficient, modular synthesis of oxazolines 
derivatives bearing fully substituted exo double bonds. 
Transition metal-catalyzed ring closures of alkyne deriva-
tives are powerful tools for the construction of heterocyclic 
molecules.
1
 With the utilization of hypervalent iodonium salts, 
2
 the cyclization step can be extended with an additional C-C 
bond formation using an in situ electrophilic aryl-copper(III) 
species.
3
 In our laboratory, we developed an arylation-ring 
closure strategy enables for the formation of new carbacyclic 
and heterocyclic molecules via endo-dig cyclization, providing 
easy access to fully substituted exo double bonds. With the 
exploitation of the synthetic opportunities of this catalytic 






(Scheme 1). The utilization of diaryliodonium salts in this 
transformation ensures the high modularity of the methodolo-
gy. 
In continuation of our research devoted to the study of cop-
per catalyzed cyclization-arylations with hypervalent reagents, 
we aimed to extend our synthetic strategy to the construction 
of five-membered heterocycles such as oxazolines equipped 
with fully substituted exo double bonds. To achieve this goal 
we aimed to use propargylic amides as substrates (Scheme 1). 
The electrophile mediated or transition metal catalyzed cycli-
zations of propargylic amides to the corresponding oxazolines 
and oxazoles are important synthetic tools for the access of a 
heterocyclic core
6
 with significant pharmaceutical interest.
7 
Although, the existing catalytic transformations enable the 
cyclization of both terminal and internal propargylic amides,
6
 
there is no synthetic methodology to the access of oxazolines 
equipped with fully substituted exo double bonds.  
Scheme 1. Utilization of arylation-ring closure strategy 
 The optimization study of the transformation was 
performed with N-(3-phenylprop-2-ynyl)pivalamide (1a). This 
model substrate was treated with mesityl(phenyl)iodonium 
triflate (2a) in the presence of transition-metal catalysts in 
various solvents under argon. We found that the propargyla-
  
2 
mide was transformed with full conversion in the presence of 
2.5 mol % of CuCl in ethyl acetate at 50 °C. The major reac-
tion product 3a was isolated in 60% yield and determined to 
be 2-tert-butyl-5-(diphenylmethylene)-4,5-dihydrooxazole by 
NMR analysis. 




Entry Catalyst Solvent Temp. 
Conv.b 
% 
1 - DCE 50 °C 0 
2 Cu(OTf)2 DCE 50 °C 11 
3 Cu(OTf)2 CH2Cl2 50 °C 31 
4 Cu(OTf)2 toluene 50 °C 5 
5 Cu(OTf)2 THF 50 °C 59 
6 Cu(OTf)2 EtOH 50 °C 0 
7 Cu(OTf)2 EtOAc 50 °C 100 
8 Cu(II)acac EtOAc 50 °C 0 
9 CuSO4 EtOAc 50 °C 0 
10 Cu(MeCN)4OTf EtOAc 50 °C 100 
11 CuO EtOAc 50 °C 0 
12 CuI EtOAc 50 °C 0 
13 CuBr EtOAc 50 °C 76 
14 CuCl EtOAc 50 °C 100 
15 CuCl EtOAc 25 °C 0 
16 5 mol% CuCl EtOAc 50 °C 100c 
17 2.5 mol% CuCl EtOAc 50 °C 100c 
a Catalyst (0.01 mmol, 0.10 equiv.), N-(3-phenylprop-2-yn-1-
yl)pivalamide (0.1 mmol, 1.0 equiv.), mesitylphenyliodonium 
triflate (0.12 mmol, 1.2 equiv.), solvent (1.0 mL), Ar. b % conver-
sions of N-(3-phenylprop-2-yn-1-yl)pivalamide were determined 
by GC-MS. c N-(3-phenylprop-2-yn-1-yl)pivalamide (0.5 mmol, 
1.0 equiv.), mesitylphenyliodonium triflate (0.6 mmol, 1.2 
equiv.), EtOAc (5.0 mL), Ar, 50 °C. 
For the implementation of the syntheses we choose simple 
propargylamine as a readily available building block, which 
can be functionalized through the N-acylation of the amine 
function and via Sonogashira chemistry at the alkyne moiety 
providing versatile substrate pool.  
To examine the scope and limitation of this novel transfor-
mation, different N-(3-arylprop-2-ynyl)pivalamides were 
treated with mesitylphenyliodonium triflate applying the opti-
mized reaction conditions (Scheme 2.). It was found that the 
presence of methyl group in ortho and para positions caused a 
slight increase in isolated yields compared to the phenyl-
propynylamide derivative 3a. The desired compounds (3b and 
3c) were obtained in 76% and 66% yields respectively. Sur-
prisingly when strong electron donating methoxy group was 
present on the phenyl group, the appropriate product 3d was 
obtained only in lower yield (34%). Presence of ester- and 
acetyl groups in the aromatic ring was tolerated by the system 
and the appropriate dihydrooxazoles (3e and 3f) were obtained 
in 65% and 86% yields. Arylpropynylpivalamides substituted 
with halogens (Cl, Br) were transformed to the appropriate 
dihydrooxazoles (3g and 3h) in 69% and 85% yields. When 
the aryl group was exchanged to thiophenyl group the reaction 
afforded the desired product (3i) in 56% yield. In cases where 
nonsymmetrical substituted (arylphenylmethylene)-
dihydrooxazoles are formed. NMR measurements confirmed 
the selective formation of the isomer where the oxygen and the 
phenyl group transferred from the iodonium salt are oriented 
cis to one another.  
Scheme 2. Synthesis of dihydrooxazoles 1.
a
 
a CuCl (0.0125 mmol, 0.025 equiv.), 3-arylpropargyl amide (0.5 
mmol, 1.0 equiv.), arylmesityliodonium triflate (0.6 mmol, 1.2 
equiv.), EtOAc (5.0 mL), Ar, 50 °C, % isolated yield 
Next we investigated the effect of the amide functionality 
on the reaction. Although, the presence of ethyl group tolerat-
ed the reaction conditions and the 2-ethyloxazoline (3j) was 
isolated in 51% yield, we were not able to isolate product (3k) 
from the trifluoroacetamide. Besides alkyl amides, several aryl 
amides were subjected to ring closure under the developed 
copper catalyzed conditions. As a result we successfully iso-
lated the phenyl (3l), p-methoxyphenyl (3m) and p-
nitrophenyl (3n) derivatives in 52%, 70% and 50% yield re-
spectively. 
After examining the applicability of different arylpropynyl 
anilides we studied the reactivity of different substituted aryl-
mesityliodonium triflates in the cyclization reaction with 
propynyl-pivalamide derivatives (Scheme 3.). The presence of 
substituents in the ortho position on the aromatic ring of the 
iodonium salt had deleterious effect on the reaction, and the 
  
3  
appropriate oxazolines (3o-3q) did not form. The transfor-
mation is compatible with various substituents in meta- and 
para positions on the phenyl group of the iodonium salt (Me, 
Cl, Br, Ac, COOEt) and the desired oxazolines (3r-3v) were 
isolated in 40-64% yield.  
Scheme 3. Synthesis of dihydrooxazoles 2.
a
 
 a CuCl (0.0125 mmol, 0.025 equiv.), 3-arylpropargyl amide (0.5 
mmol, 1.0 equiv.), arylmesityliodonium triflate (0.6 mmol, 1.2 
equiv.), EtOAc (5.0 mL), Ar, 50 °C, % isolated yield 
Finally, reactions were performed with propynylamides and 
iodonium triflates bearing substituents (Me, Br, Cl, COOEt) 
on both aryl groups of the reactants. The expected dihydroox-
azoles (3w-3z) with symmetrical substituted double bond were 
isolated in 54%, 61%, 63%, and 45% yield respectively.  
Figure 1. Molecular structure of compound 3c.
8
 Displace-




The geometries of the obtained non-symmetrically substi-
tuted heterocyclic alkene products (3r-3v) were determined by 
NMR studies and it was found that the incoming aryl group 
originated from the iodonium salt was in cis position to the 
oxygen of the oxazolines ring. The geometry of the exo double 
bound on the oxazoline ring was also established by X-ray 
crystallography in case of compound 3c (Figure 1.). 
On the basis of the previously reported mechanistic pro-
posals of related transformations and the obtained geometry of 
the oxazolines, we propose the following mechanistic picture 
for the transformation (Scheme 4). Recent reports have shown 
that the reaction of copper salts and diaryliodonium salts gen-
erate aryl-Cu(III) species.
3 
These copper(III)-species are gen-
erally highly electrophilic and can easily react with electron 
rich π-systems. Thus we propose that the catalytic cycle starts 
with the oxidation of CuCl by the iodonium salt which leads to 
the formation of a highly electrophilic Ar-CuCl(OTf) interme-
diate. We suppose that this Cu(III)-species can coordinate both 
to the triple bond and the lone pair of the carbonyl oxygen 
from the inner sphere. The electrophilic metal species acti-
vates the triple bond, forming a copper – acetylene π complex, 
then formation of the carbocationic species is also possible. 
The lone pair of the amide nitrogen serves as the electron 
source, and the oxygen of the amide moiety attacks to the 
activated  complex (path a) or to the carbocationic center 
(path b) which results a 5-exo-dig cyclization. The formed 
alkenyl(aryl)copper intermediate is able to undergo reductive 
elimination-deprotonation sequence in two supposed order 
providing the CuCl catalyst and the oxazoline product. 
Scheme 4. Proposed mechanistic picture of the transfor-
mation. 
Summarizing our results, in this work we demonstrated that 
the copper catalyzed ring closure-carboarylation strategy can 
be extended to substrates bearing alkyne and amide groups. 
We successfully achieved the synthesis of novel oxazoline 
derivatives equipped with fully substituted exo double bonds 
in the reaction of arylpropargylicamides and diaryliodonium 
salts. The versatile and readily available starting materials 
ensure high modularity for the transformation, and the opti-
mized reaction conditions enable the efficient synthesis of the 
target compounds. Further exploitation of the cyclization-
arylation strategy for other alkyne derivatives functionalized 
with different nucleophilic part undergoes in our laboratory. 
ASSOCIATED CONTENT  
Supporting Information 
Experimental procedures, characterization data, and NMR spectra 
for all compounds. This material is available free of charge via the 





* novakz@elte.hu  
Author Contributions 
The manuscript was written through contributions of all authors. / 
All authors have given approval to the final version of the manu-
script. 
ACKNOWLEDGMENT  
The financial support of Servier, as well as the contribution of the 
Hungarian Academy of Sciences (“Lendület” Research Scholar-
ship) (LP2012-48/2012), and TÉT-10-1-2011-0245 is gratefully 
acknowledged. The authors also thank Prof. Tim Peelen (Lebanon 
Valley College) for the proofreading of this manuscript.  
REFERENCES 
 
(1) (a) Humphrey, G. R.; Kuethe, J. T. Chem. Rev. 2006, 106, 
2875. (b) Zeni, G.; Larock, R. C. Chem. Rev. 2006, 106, 4644. (c) 
Cacchi, S.; Fabrizi, G. Chem. Rev. 2005, 105, 2873. (d) Zeni, G.; 
Larock, R. C. Chem. Rev. 2004, 104, 2285. (e) Nakamura, I.; Yama-
moto, Y. Chem. Rev. 2004, 104, 2127. g) Patil, N. T.; Yamamoto, Y. 
Chem. Rev. 2008, 108, 3395. 
(2) (a) Stang, P. J.; Zhdankin, V. V. Chem. Rev. 1996, 96, 1123. (b) 
Zhdankin, V. V.; Stang, P. J. Chem. Rev. 2002, 102, 2523. (c) 
Zhdankin, V. V.; Stang, P. J. Chem. Rev. 2008, 108, 5299. (d) Merritt 
E.A.; Olofsson B. Angew. Chem. Int. Ed. 2009, 48, 9052. (e) V. V. 
Zhdankin, Hypervalent Iodine Chemistry, Wiley, Chichester 2014. (f) 
J. Collette, D. McGreer, R. Crawford, F. Chubb, R. B. Sandin, J. Am. 
Chem. Soc. 1956, 78, 3819-3820. (g) G. F. Koser, R. H. Wettach, C. 
S. Smith, J. Org. Chem. 1980, 45, 1543-1544. (h) P. J. Stang, V. V. 
Zhdankin, R. Tykwinski, Tetrahedron Lett. 1992, 33, 1419-1422. (i) 
E. A. Merritt, B. Olofsson, Angew. Chem. Int. Ed. 2009, 48, 9052-
9070. (j) J. M. Bouma, B. Olofsson, Chem. Eur. J. 2012, 18, 14242-
14245. (k) M. Bielawski, B. Olofsson, Chem. Commun. 2007, 25, 
2521-2523. (l) M. S. Yusubov, A. V. Maskaev, V. V. Zhdankin, 
ARKIVOC 2011, 370-409. (m) L. F. Silva, Jr., B. Olofsson, Nat. Prod. 
Rep. 2011, 28, 1722-1754. (n) Tinnis, F. Stridfeldt, E.; Lundberg, 
H.;Adolfsson, H.;Olofsson, B. Org. Lett. 2015, 17, 2688-2691. (o) 
Ghosh, R.; Stridfeldt, E.; Olofsson, B. Chem. Eur. J. 2014, 20, 8888-
8892. 
(3) (a) R. J. Phipps, N. P. Grimster, M. J. Gaunt, J. Am. Chem. Soc. 
2008, 130, 8172-8174. (b) R. J. Phipps, M. J. Gaunt, Science 2009, 
323, 1593-1597. (c) R. J. Phipps, L. Mc Murray, S. Ritter, H. A. 
Duong, M. J. Gaunt, J. Am. Chem. Soc. 2012, 134, 10773-10776. (d) 
A. Bigot, A. E. Williamson, M. J. Gaunt, J. Am. Chem. Soc. 2011, 
133, 13778-13781. (e) M. G. Suero, E. D. Bayle, B. S. L. Collins, M. 
J. Gaunt, J. Am. Chem. Soc. 2013, 135, 5332-5335. (f) A. J. 
Walkinshaw, W. Xu, M. G. Suero, M. J. Gaunt, J. Am. Chem. Soc. 
2013, 135, 12532-12535. (g) E. Cahard, N. Bremeyer, M. J. Gaunt, 
Angew. Chem. Int. Ed. 2013, 52, 9284-9288. (h) F. Zhang, S. Das, A. 
J. Walkinshaw, A. Casitas, M. Taylor, M. G. Suero, M. J. Gaunt, J. 
Am. Chem. Soc. 2014, 136, 8851-8854. (i) A. E. Allen, D. W. C. 
MacMillan, J. Am. Chem. Soc. 2011, 133, 4260-4263. (j) J. H. Ryan, 
P. J. Stang, Tetrahedron Lett. 1997, 38, 5061-5064. (k) A. Casitas, X. 
Ribas, Chem. Sci. 2013, 4, 2301-2318. (l) Buksnaitiené, R.; Cikotiené, 
I.; 2015, 26, 479-483. (m) Peng, J.; Chen, C.; Chen, J.; Su, X.; Xi, C.; 
Chen, H. Org. Lett. 2014, 16, 1776-1779. (o) Cahard, E.; Male, H. P. 
J.; Tissot, M.; Gaunt, M. J. J. Am. Chem. Soc. 2015, DOI: 
10.1021/jacs5b03937 
(4) (a) Sinai, Á.; Mészáros, Á.; Gáti, T.; Kudar, V.; Palló A.; No-
vák, Z. Org. Lett. 2013, 15, 5654-5657. (b) Székely, A.; Sinai, Á.; 
Tóth, E. B.; Novák, Z. Synthesis 2014, 46, 1871; 
(5) Aradi, K.; Novák, Z. Adv. Synth. Catal. 2015, 357, 371-376. 
(6) (a) Hashmi, A. S. K.; Schuster, A. M.; Schmuck, M.; Rominger 
F. Eur. J. Org. Chem. 2011, 4595-4602. (b) Bacchi, A.; Costa, M.; 
Gabriele, B.; Pelizzi, G.;Salerno, G.; J. Org. Chem. 2002, 67, 4450-
4457. (c) Costa, M.; Ca, N. D.; Gabriele, B.; Massera, C.; Salerno, G.; 
Soliani, M.; J. Org. Chem. 2004, 69, 2469-2477. (d) Hashmi, A. S. 
K.; Jaimes, M. B. C.; Schuster, A. M.; Rominger, F.; J. Org. Chem. 
2012, 77, 6394-6408. (e) Wipf, P.; Aoyama, Y.; Benedum, T. E.; Org. 
Lett. 2004, 6, 3593-3595. (f) Chang, M.-Y.; Cheng, Y.-C.; Lu, Y.-J.; 
Org. Lett. 2015, 17, 1264-1267. (g) Huang, H.; He, G.; Zhu, X.; Qiu, 
S.; Zhu, H.; J. Org. Chem. 2015, 80, 3480-3487. (h) Wang, M.; Jiang, 
M.; Liu, J.-.T. Org. Chem. Front. 2015, 2, 542-547. (i) Senadi, G. C.; 
Hu, W.-P.;Hsiao, J-S.;Vandavasi, J. K.;Chen, C.-Y.;Wang, J.-J. Org. 
Lett. 2012, 4478-4481. (j) Arcadi, A.;Cacchi, S.; Cascia, L.; Fabrizi, 
G.; Marinelli, F. Org. Lett. 2001, 3, 2501-2504; (k) Jin, C.; Burgess, J. 
P. Kepler, J. A.; Cook, C. E. Org. Lett. 2007, 9, 1887-1890. (l) 
Weyrauch, J. P.; Hashmi, A. S. K.; Schuster, A. M.; Hengst, T.; 
Schetter, S. Littmann, A.; Rudolph, M.; Hamzic, M.;Visus, J.; 
Rominger, F.; Frey, W.;Bats, J. W. Chem. Eur. J. 2010, 16, 956–963 
(7) (a) Stefely, J. A.; Palchaudhuri, R.; Miller, P. A.; Peterson, R. 
J.; Moraski, G. C.; Hergenrother, P. J.; Miller, M. J. J. Med. Chem. 
2010. 53, 3389-3395. (b) Li, Q.; Wood, K. W.; Claireborne, A.; 
Gwanltey, S. L., II; Barr, K. J.; Liu, G.; Gehke, L.; Credo, R. B.; Hua 
Hui, Y.; Lee, J.; Warner, R. B.; Kovar, P.; Nukkla, M. A.; Zielinski, 
N. A.; Tahir, S. K.; Fitzgerald, M.; Kim, K. H.; Marsh, K.; Frost, D.; 
Ng, S.-C.; Rosenberg, S.; Sham, H. L. Bioorg. Med. Chem. 2002, 12, 
465-469 
(8) Crystallographic data for the crystal structure of 3c have been 
deposited with the Cambridge Crystallographic Data Centre as sup-
plementary publication number CCDC 1045312 
(9) C.F. Macrae, P.R. Edgington, P. McCabe, E. Pidcock, G.P. 
Shields, R. Taylor, M. Towler and J. van de Streek, J. Appl. Cryst. 
2006, 39, 453. 
  
  
5 
 
